Literature DB >> 3926501

The fluorescent immunosorbent test for IgG gliadin antibodies and the leucocyte migration inhibition test in coeliac disease; comparison of diagnostic value.

R M Bertele, A Bürgin-Wolff, R Berger, R M Gorny, H K Harms.   

Abstract

The diagnostic value of the fluorescent immunosorbent test for IgG gliadin antibodies (FIST) has been investigated in comparison with the LIF test--the competence of the gluten subfractions B2 and B3 in releasing lymphokines from peripheral lymphocytes in vitro--in 96 patients with coeliac disease (CD) under various dietary conditions. In untreated children with CD during their first 2 years of life, the FIST showed 100% sensitivity with 95% specificity, whilst the LIF test showed only 70% sensitivity and 73% specificity. Therefore it can be concluded that the FIST as a screening test is superior to the LIF. In older children with a proved recurrence of the mucosal abnormality after reintroduction of a normal diet, only 44% showed increased IgG gliadin antibody titres whereas 70% proved to be positive in the LIF test. Under a controlled gluten challenge all six patients reacted with a distinct increase in gliadin antibody titres whereas the LIF test changed from positive to negative and vice versa without following any clear principle. These results emphasize the inadequacy of the LIF test as a diagnostic method, both in untreated CD and under controlled gluten challenge.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926501     DOI: 10.1007/bf00491928

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  Criteria for diagnosis of temporary gluten intolerance.

Authors:  A S McNeish; C J Rolles; L J Arthur
Journal:  Arch Dis Child       Date:  1976-04       Impact factor: 3.791

2.  Assay of intestinal disaccharidases.

Authors:  A Dahlqvist
Journal:  Anal Biochem       Date:  1968-01       Impact factor: 3.365

3.  Cell-mediated immunity to gluten fraction III in adult coeliac disease.

Authors:  A W Bullen; M S Losowsky
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

4.  An in-vitro immunological assay for diagnosis of coeliac disease.

Authors:  A Ashkenazi; D Idar; Z T Handzel; M Ofarim; S Levin
Journal:  Lancet       Date:  1978-03-25       Impact factor: 79.321

5.  Stimulation of lymphocytes from patients with coeliac disease by a subfraction of gluten.

Authors:  K Sikora; B S Anand; S C Truelove; P J Ciclitira; R E Offord
Journal:  Lancet       Date:  1976-08-21       Impact factor: 79.321

6.  Effect of gluten-free diet on an immunological assay for coeliac disease.

Authors:  A Ashkenazi; S Levin; D Idar; A Or; N Barzilai; Z T Handzel
Journal:  Lancet       Date:  1981-04-25       Impact factor: 79.321

7.  Immunofluorescent antibodies against gliadin: a screening test for coeliac disease.

Authors:  A Bürgin-Wolff; R Hernandez; M Just; E Signer
Journal:  Helv Paediatr Acta       Date:  1976-12

8.  IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease.

Authors:  E Savilahti; M Viander; M Perkkiö; E Vainio; K Kalimo; T Reunala
Journal:  Lancet       Date:  1983-02-12       Impact factor: 79.321

9.  Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease.

Authors:  A Ferguson; T T MacDonald; J P McClure; R J Holden
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

10.  The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN).

Authors:  A S McNeish; H K Harms; J Rey; D H Shmerling; J K Visakorpi; J A Walker-Smith
Journal:  Arch Dis Child       Date:  1979-10       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.